Detalhe da pesquisa
1.
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study.
Blood
; 135(8): 534-541, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31877211
2.
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.
Blood
; 122(25): 4111-8, 2013 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24152907
3.
Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphoma.
Biol Blood Marrow Transplant
; 18(2): 241-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21791194
4.
Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients.
Front Immunol
; 13: 892331, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36003404
5.
Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside.
ScientificWorldJournal
; 11: 1908-31, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22125447
6.
Expression of some ATP-binding cassette transporters in acute myeloid leukemia.
Hematol Rep
; 9(4): 7406, 2017 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29333226
7.
The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells.
Endocr Relat Cancer
; 18(1): 1-11, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20943719